Gene · 6716
Papers1,787
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,787
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Validation of steroid ratios for random urine by mass spectrometry to detect 5α-reductase deficiency in Vietnamese children. | Clin Chem Lab Med | 2022 | 35607271 | PubTator, text mining | PubMed |
| Phenotype expansion of variants affecting p38 MAPK signaling in hypospadias patients. | Orphanet J Rare Dis | 2022 | 35606856 | PubTator, text mining | PubMed |
| Effects of red ginseng oil(KGC11o) on testosterone-propionate-induced benign prostatic hyperplasia. | J Ginseng Res | 2022 | 35600774 | PubTator, text mining | PubMed |
| Isolation and HPLC Quantitative Determination of 5α-Reductase Inhibitors from Tectona grandis L.f. Leaf Extract. | Molecules | 2022 | 35566245 | PubTator, text mining | PubMed |
| Whole exome sequencing applied to 42 Han Chinese patients with posterior hypospadias. | Steroids | 2022 | 35561789 | PubTator, text mining | PubMed |
| Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment. | Theranostics | 2022 | 35547773 | PubTator, text mining | PubMed |
| An extract of Leontopodium alpinum inhibits catagen development ex vivo and increases hair density in vivo. | Int J Cosmet Sci | 2022 | 35514231 | PubTator, text mining | PubMed |
| Prognostic impact of dose reduction in androgen receptor pathway inhibitors for castration-resistant prostate cancer. | Prostate Int | 2022 | 35510101 | PubTator, text mining | PubMed |
| Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena. | J Hematol Oncol | 2022 | 35505417 | PubTator, text mining | PubMed |
| Precision intervention for prostate cancer: Re-evaluating who is at risk. | Cancer Lett | 2022 | 35490919 | PubTator, text mining | PubMed |
| [Analysis of clinical phenotype and genotype of Chinese children with disorders of sex development]. | Zhonghua Er Ke Za Zhi | 2022 | 35488637 | PubTator, text mining | PubMed |
| Identification of Small Regions of Overlap from Copy Number Variable Regions in Patients with Hypospadias. | Int J Mol Sci | 2022 | 35457073 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings. | Front Endocrinol (Lausanne) | 2022 | 35432193 | PubTator, text mining | PubMed |
| The CAG-triplet in the androgen receptor gene and single-nucleotide polymorphisms in androgen pathway genes in patients with concomitant bladder and prostate cancer. | Urol Oncol | 2022 | 35431136 | PubTator, text mining | PubMed |
| The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer. | Front Cell Dev Biol | 2022 | 35399507 | PubTator, text mining | PubMed |
| An Extremely Rare SRD5A2 Gene c.485A>C Mutation in a Compound Heterozygous Newborn with Disorders of Sex Development First Identified in Vietnam. | Case Rep Endocrinol | 2022 | 35386187 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia. | Syst Rev | 2022 | 35382870 | PubTator, text mining | PubMed |
| Impact of chronic exposure of rats to bisphenol A from perinatal period to adulthood on intraprostatic levels of 5α-reductase isozymes, aromatase, and genes implicated in prostate cancer development. | Environ Res | 2022 | 35378123 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6716/papers?page=18